Skip to Content
Apply Now

Clinical Information

Load More

Disclaimer: DaxibotulinumtoxinA for Injection is currently an investigational product and not approved by FDA. Anticipated approval in 2020.

*DaxibotulinumtoxinA for Injection was formerly known as RT002.

Back to top